Nektar Therapeutics
Symbol: NKTR (NASDAQ)
57.35
▲ (0.79%) 0.450
Company Description:
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
Key Stats
- Today's Open: $57.35
- Today's High: $57.35
- Today's Low: $57.35
- Today's Volume: 10
- Yesterday Close: $56.9
- Yesterday High: $59.2
- Yesterday Low: $56.85
- Yesterday Volume: 1.02M
- Last Min Volume: 6
- Last Min High: $57.35
- Last Min Low: $57.35
- Last Min VWAP: $57.35
Company Profile
- Name: Nektar Therapeutics
- Website: https://www.nektar.com
- Listed Date: 1994-05-03
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0000906709
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.08B
- Round Lot: 100
- Outstanding Shares: 19.02M
- Asset Type: CS
RECENT FILINGS FOR NKTR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-18 | 8-K | View |
| 2025-09-11 | 4 | View |
| 2025-09-09 | 144 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-05 | 144 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 144 | View |
| 2025-09-04 | 144 | View |
| 2025-09-02 | 144 | View |
| 2025-09-02 | 144 | View |
| 2025-08-21 | 4 | View |
| 2025-08-21 | 4 | View |
| 2025-08-21 | 4 | View |
| 2025-08-19 | 144 | View |
| 2025-08-19 | 144 | View |
| 2025-08-19 | 144 | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
Latest News on NKTR